Winrex Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 25-12-2024
- Paid Up Capital ₹ 1.95 M
as on 25-12-2024
- Company Age 28 Year, 3 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 6.38 M
as on 25-12-2024
About Winrex Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.95 M.
The company currently has active open charges totaling ₹6.38 M.
Srinivasa Nannamuri and Kancherlae Rao serve as directors at the Company.
- CIN/LLPIN
U45200TG1996PTC025367
- Company No.
025367
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Oct 1996
- Date of AGM
26 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Winrex Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Nannamuri  | Managing Director | 12-Mar-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kancherlae Rao | Additional Director | 14-Mar-2012 | Current |
Financial Performance of Winrex Pharmaceuticals.
Enhance accessibility to Winrex Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Winrex Pharmaceuticals?
Unlock access to Winrex Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Pradesh State Financial Corporation Creation Date: 31 Dec 2008 | ₹2.00 M | Open |
Andhra Predesh State Financial Cor. Creation Date: 19 Jul 2004 | ₹1.00 M | Open |
Andhra Predesh State Financial Cor. Creation Date: 28 Feb 2002 | ₹1.00 M | Open |
How Many Employees Work at Winrex Pharmaceuticals?
Winrex Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winrex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winrex Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
